Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

John James

John James

OBE
Sickle Cell Society
The LISTEN survey: motivators and barriers to participation in sickle cell disease clinical trials 2:51
The LISTEN survey: motivators and barriers to participation in sickle cell disease clinical trials
John James • 13 Oct 2025
The impact of the withdrawals of crizanlizumab and voxelotor on patients with SCD in the UK 5:43
The impact of the withdrawals of crizanlizumab and voxelotor on patients with SCD in the UK
John James • 13 Oct 2025
The work of the Sickle Cell Society: supporting patients and improving SCD research 4:24
The work of the Sickle Cell Society: supporting patients and improving SCD research
John James • 13 Oct 2025
An insight into the role of the Sickle Cell Society 2:05
An insight into the role of the Sickle Cell Society
John James • 4 Apr 2022
The role of clinical trials in improving treatment options for SCD 0:55
The role of clinical trials in improving treatment options for SCD
John James • 4 Apr 2022
The APPG report on poor quality care for SCD 1:22
The APPG report on poor quality care for SCD
John James • 4 Apr 2022
The content of VJHemOnc is intended for healthcare professionals